Forbes online interview, page-14

Isn't it fundamentally obvious? The main thrust of MSB was always to treat ARDS, never COVID-19 itself. The virus doesn't kill people, the over-reaction of the body's immune system does. Remestemcel-L was always aimed at treating the cyctokine storms and related over inflammatory reaction that COVID-19 encourages in some people. SI couldn't have been any clearer.

He is being realistic. Anyway, if a vaccine emerges it will not be foolproof. Flu vaccines run at about 50-70% effectiveness. Coronavirus vaccines have never been successfully produced. Even if one is there are still going to be plenty of ARDS cases before and even after a vaccine is produced. 40% of flu deaths (and they can still approach 1 million globally) are from ARDS. Many deaths from Sepsis from ARDS. ARDS will continue to be a huge issue even if a vaccine for COVID-19 is produced.

MSB is going to be the gold star treatment for the worse effects of COVID-19, not addressing COVID-19 directly. That is huge in the battle against this pandemic. Hopefully the powers that be catch on and Remestemcel-L is taken quickly so hundreds of thousands need not die before a vaccine comes to fruition.